Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation-Reference-Cited by-同舟云学术

Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation

Published:2010-11-22 Issue:12 Volume:31 Page:1643-1648
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Tan Wei-feng,Qiu Zhi-quan,Yu Yong,Ran Rong-zheng,Yi Bing,Lau Wan-yee,Liu Chen,Qiu Ying-he,Feng Fei-ling,Wang Jing-han,Yan Pei-ning,Zhang Bai-he,Wu Meng-chao,Luo Xiang-ji,Jiang Xiao-qing

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/aps2010124.pdf

Reference22 articles.

1. Parkin DM, Bray F, Ferlay J, Pisani P . Global cancer statistics. CA Cancer J Clin 2005; 55: 74–108.

2. Yates MS, Kensler TW . Keap1 eye on the target: chemoprevention of liver cancer. Acta Pharmacol Sin 2007; 28: 1331–42.

3. Sherman M . Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 2005; 25: 143–54.

4. Llovet JM, Burroughs A, Bruix J . Hepatocellular carcinoma. Lancet 2003; 362: 1907–17.

5. Mi JX, Wang GF, Wang HB, Sun XQ, Ni XY, Zhang XW, et al. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma. Acta Pharmacol Sin 2008; 29: 1467–77.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy and safety of multimodality treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: patient-level network meta-analysis;Frontiers in Oncology;2024-02-16

2. Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments;Transplantation;2022-08-02

3. The Outcomes of Systemic Treatment in Recurrent Hepatocellular Carcinomas Following Liver Transplants;Advances in Therapy;2021-06-01

4. Therapeutic Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Recurrence After Liver Transplantation: A Systematic Review and Meta-Analysis;The Turkish Journal of Gastroenterology;2021-04-13

5. The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysis;World Journal of Surgical Oncology;2020-09-11